688606 Hangzhou Alltest Biotech
- 68.75
- -0.58-0.84%
Hangzhou Alltest Biotech News
Notice on the progress of voluntary disclosure of foreign investment industrial funds
Aotai Biotech: Announcement of Resolutions of the 2024 Third Extraordinary General Meeting of Shareholders
Aotai Biotech: Legal Opinion of Shanghai Lifeng Law Firm on the 2024 Third Extraordinary General Meeting of Shareholders of Hangzhou Aotai Biotechnology Co., Ltd.
Announcement of Resolutions of the 2024 Third Extraordinary General Meeting of Shareholders
Legal Opinion of Shanghai Lifeng Law Firm on the 2024 Third Extraordinary General Meeting of Shareholders of Hangzhou Aotai Biotechnology Co., Ltd.
2024 3rd Extraordinary General Meeting of Shareholders Meeting Materials
Notice on convening the 3rd Extraordinary General Meeting of Shareholders in 2024
Legal Opinion of Shanghai Lifeng Law Firm on the 2024 Second Extraordinary General Meeting of Shareholders of Hangzhou Aotai Biotechnology Co., Ltd.
Announcement of Resolutions of the 2024 Second Extraordinary General Meeting of Shareholders
2024 Second Extraordinary General Meeting of Shareholders Meeting Materials
Notice of Hangzhou Aotai Biotechnology Co., Ltd. on convening the 2nd Extraordinary General Meeting of Shareholders in 2024
Announcement of Hangzhou Aotai Biotechnology Co., Ltd. on the launch of foreign exchange derivatives trading business
Legal Opinion of Shanghai Lifeng Law Firm on the 2023 Annual General Meeting of Shareholders of Hangzhou Aotai Biotechnology Co., Ltd.
Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Announcement of Hangzhou Aotai Biotechnology Co., Ltd. on additional provisional proposals for the 2023 Annual General Meeting of Shareholders
2023 Annual General Meeting of Shareholders Meeting Materials
2023 Internal Control Evaluation Report
2023 Board Audit Committee Performance Report
Report on the performance of supervisory duties by the Board of Directors and the Audit Committee on the accounting firm
2024 “Improve Quality, Increase Efficiency, and Focus on Return” Action Plan
Analysis
Price Target
No Data
No Data